OPIANT PHARMACEUTICALS, INC. DIRECTOR AGREEMENTDirector Agreement • March 22nd, 2021 • Opiant Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionThis DIRECTOR AGREEMENT (this “Agreement”) by and between Dr. Lorianne Masuoka (“Director”) and Opiant Pharmaceuticals, Inc. (“Company”), with its corporate headquarters at 233 Wilshire Blvd., Suite 280, Santa Monica, CA 90401, is dated and effective as of March 18, 2021 (the “Appointment Date”).